CME
Latest Episodes
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
Host: Paul P. Doghramji, MD, FAAFP Guest: Nina Delaney Wagner-Johnston, MD Guest: Seema A. Bhat, MD Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy associated with different cytogenetic, immunophenotypic, and morphological p
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE Guest: Leslie Cho, MD More than 15 professional societies now recommend the use of icosapent ethyl to treat atherosclerotic cardiovascular disease (ASCVD), but clinical questions about the use of ome
RAASi Therapy, Diabetes, and Hyperkalemia: Halting Therapy Is NOT the Only Option
Host: George Bakris, MD Guest: Biff F. Palmer, MD In this case-based activity, Drs. George Bakris and Biff Palmer discuss the benefits of RAAS inhibitors in the patient diagnosed with diabetes, hypertension, and chronic kidney disease. They review
Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Anna-Barbara Moscicki, MD Updated cervical cancer screening guidelines were published by both the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Cancer Society (ACS). Dr
Act Fast: Understanding Flu Prevention and Treatment in At-Risk Populations
Host: Cassandra B. Donnelly, DO Guest: Charles P. Vega, MD Antiviral agents are underutilized against influenza in clinical practice, a failure that places many patients, especially those with comorbidities, at high risk for influenza-associated co
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy - Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D
Guest: Kevan C. Herold, MD Guest: Andrea Steck, MD Guest: Anette Gabriele Ziegler, MD Experts in the immunopathology of type 1 diabetes review data showing that clinical presentation is preceded by an asymptomatic phase, characterized by the pres
How ADCs Are Transforming HER2+ Metastatic Breast Cancer: Discover the Latest Clinical Trend
Guest: Javier Cortes, MD, PhD Guest: Sara A. Hurvitz, MD, FACP While HER2+ breast cancers are traditionally associated with a poor prognosis, the development of HER2-directed treatment strategies has led to substantial and durable survival improvem
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
Host: Paul W. Armstrong, MD Guest: Justin Ezekowitz, MD, MBBCh, MSc Is it possible to reduce the nearly 60% one-month rehospitalization rates in patients with worsening heart failure? Dr. Paul Armstrong and Dr. Justin Ezekowitz discuss new therapeu
Calibrating COVID-19: The Interplay of Disease Modifying Therapy and Vaccination in Patients with Multiple Sclerosis
Host: Adnan Subei, DO Guest: Robert Bermel, MD Guest: Claire Riley, MD The emergence of COVID-19 has created an unprecedented medical emergency that both raises new questions and presents updated information each day. This issue is even more pres
The Clinical Significance of Imaging in the Management of ADPKD
Guest: Jimmy T. Lee, MD Guest: Arlene B. Chapman, MD This Expert Exchange webcast aims to better define the importance radiological imaging plays in the management of patients with autosomal dominant polycystic kidney disease (ADPKD).